Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
TP53 (which encodes p53) is one of the most frequently mutated genes in cancers. In this study, we generated TP53-mutant pigs by gene editing via electroporation of the Cas9 protein (GEEP), a process that involves introducing the Cas9 protein and single-guide RNA (sgRNA) targeting exon 3 and intron 4 of TP53 into in vitro-fertilized zygotes. Zygotes modified by the sgRNAs were transferred to recipients, two of which gave birth to a total of 11 piglets. Of those 11 piglets, 9 survived. Molecular genetic analysis confirmed that 6 of 9 live piglets carried mutations in TP53, including 2 piglets with no wild-type (WT) sequences and 4 genetically mosaic piglets with WT sequences. One mosaic piglet had 142 and 151 bp deletions caused by a combination of the two sgRNAs. These piglets were continually monitored for 16 months and three of the genome-edited pigs (50%) exhibited various tumor phenotypes that we presumed were caused by TP53 mutations. Two mutant pigs with no WT sequences developed mandibular osteosarcoma and nephroblastoma. The mosaic pig with a deletion between targeting sites of two sgRNAs exhibited malignant fibrous histiocytoma. Tumor phenotypes of TP53 mosaic mutant pigs have not been previously reported. Our results indicated that the mutations caused by gene editing successfully induced tumor phenotypes in both TP53 mosaic- and bi-allelic mutant pigs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although this method is a primary method of Cas9-sgRNA delivery to cells ex vivo, electroporation has also been used successfully for Cas9 delivery to animal zygotes 82,83 , and to introduce CRISPR-Cas constructs directly into mouse skeletal muscle, resulting in restoration of dystrophin gene expression 84 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Pig Cloning by Microinjection of Fetal Fibroblast Nuclei
Onishi, A., Iwamoto, M., Akita, T., Mikawa, S., Takeda, K., Awata, T., Hanada, H., & Perry, A. C. F. (2000) · Science · doi:10.1126/science.289.5482.1188 · Cited by 839
Forbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp995 · Cited by 573
Advances in Swine Biomedical Model Genomics
Lunney, J. K. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.179 · Cited by 513
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Whitworth, K. M., Lee, K., Benne, J. A., Beaton, B. P., Spate, L. D., Murphy, S. L., Samuel, M. S., Mao, J., O'Gorman, C., Walters, E. M., et al. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121723 · Cited by 354
Efficient nonmeiotic allele introgression in livestock using custom endonucleases
Tan, W., Carlson, D. F., Lancto, C. A., Garbe, J. R., Webster, D. A., Hackett, P. B., & Fahrenkrug, S. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310478110 · Cited by 278
A Genetic Porcine Model of Cancer
Schook, L. B., Collares, T. V., Hu, W., Liang, Y., Rodrigues, F. M., Rund, L. A., Schachtschneider, K. M., Seixas, F. K., Singh, K., Wells, K. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128864 · Cited by 168
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2731 · Cited by 168
Gene targeting, genome editing: from Dolly to editors
Tan, W., Proudfoot, C., Lillico, S. G., & Whitelaw, C. B. A. (2016) · Transgenic Research · doi:10.1007/s11248-016-9932-x · Cited by 162
Somatic cell reprogramming-free generation of genetically modified pigs
Tanihara, F., Takemoto, T., Kitagawa, E., Rao, S., Kim, L. T., Ōnishi, A., Yamashita, Y., Kosugi, C., Suzuki, H., Sembon, S., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600803 · Cited by 129
Self-citationA Porcine Model of Familial Adenomatous Polyposis
Flisikowska, T., Merkl, C., Landmann, M., Eser, S., Rezaei, N., Cui, X., Kurome, M., Zakhartchenko, V., Keßler, B., Wieland, H., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.110 · Cited by 127
Genetically modified pigs for biomedical research
Luo, Y., Lin, L., Bolund, L., Jensen, T. G., & Sørensen, C. B. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9475-0 · Cited by 124
Genetically Modified Pig Models for Human Diseases
Fan, N., & Lai, L. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2012.07.014 · Cited by 108
Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
Sabnis, A. J., Cheung, L. S., Dail, M., Kang, H. C., Santaguida, M. A., Hermiston, M. L., Passegue, E. A., Shannon, K., & Braun, B. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000059 · Cited by 106
Development and translational imaging of a TP53 porcine tumorigenesis model
Sieren, J. C., Meyerholz, D. K., Wang, X., Davis, B. T., Newell, J. D., Hammond, E., Rohret, J. A., Rohret, F., Struzynski, J. T., Goeken, J. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75447 · Cited by 91
Luo, Y., Li, J., Liu, Y., Lin, L., Du, Y., Li, S., Yang, H., Vajta, G., Callesen, H., Bolund, L., et al. (2010) · Transgenic Research · doi:10.1007/s11248-010-9472-8 · Cited by 87
Inactivation and Inducible Oncogenic Mutation of p53 in Gene Targeted Pigs
Leuchs, S., Saalfrank, A., Merkl, C., Flisikowska, T., Edlinger, M., Durkovic, M., Rezaei, N., Kurome, M., Zakhartchenko, V., Kessler, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043323 · Cited by 82
Genetically modified pigs to model human diseases
Flisikowska, T., Kind, A., & Schnieke, A. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0182-9 · Cited by 70
Kim, L. T., Luu, V. V., Morita, Y., Taniguchi, M., Nii, M., Peter, A. T., & Otoi, T. (2015) · Reproductive Biology · doi:10.1016/j.repbio.2015.01.002 · Cited by 69
Self-citationGenetically Modified Pig Models for Human Diseases
Fan, Liangxue, & Lai (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · Cited by 64
Genetic induction of tumorigenesis in Swine
Adam, S. J., Rund, L. A., Kuzmuk, K. N., Zachary, J. F., Schook, L. B., & Counter, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209892 · Cited by 60
The new pig on the block: modelling cancer in pigs
Flisikowska, T., Kind, A., & Schnieke, A. (2013) · Transgenic Research · doi:10.1007/s11248-013-9720-9 · Cited by 58
A porcine model of osteosarcoma
Saalfrank, A., Janssen, K.-P., Ravon, M., Flisikowski, K., Eser, S., Steiger, K., Flisikowska, T., Müller-Fliedner, P., Schulze, É., Brönner, C., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.19 · Cited by 56
Li, X. F., Xiangping, Z., Guan, Y., Wáng, Y. X. J., Scutt, D., & Gong, Q. (2006) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-005-0099-8 · Cited by 45
Skipper, H. E. (1968) · Cancer · doi:10.1002/1097-0142(196804)21:4<727::aid-cncr2820210426>3.0.co;2-3 · Cited by 42
Shen, Y., Xu, K., Yuan, Z., Guo, J., Zhao, H., Zhang, X., Zhao, L., Qing, Y., Li, H., Pan, W., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1327-0 · Cited by 35
Genome Editing with CompoZr Custom Zinc Finger Nucleases (ZFNs)
Hansen, K., Coussens, M. J., Sago, J., Subramanian, S., Gjoka, M., & Briner, D. (2012) · Journal of Visualized Experiments · doi:10.3791/3304 · Cited by 32
Selek, L., Seigneuret, É., Nugue, G., Wion, D., Nissou, M. F., Salon, C., Seurin, M. J., Carozzo, C., Ponce, F., Roger, T., et al. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.10.002 · Cited by 32
McCalla-Martin, A. C., Chen, X. L., Linder, K. E., Estrada, J., & Piedrahita, J. A. (2010) · Transgenic Research · doi:10.1007/s11248-010-9362-0 · Cited by 27
Hidalgo, J., Belani, J. S., Maxwell, K. L., Lieber, D. L., Talcott, M., Baron, P., Ames, C. D., Venkatesh, R., & Landman, J. (2005) · Urology · doi:10.1016/j.urology.2004.12.002 · Cited by 22
Luo, Y., Bolund, L., & Sørensen, C. B. (2011) · Transgenic Research · doi:10.1007/s11248-011-9563-1 · Cited by 20
Malignant Fibrous Histiocytoma in the Spleen of a Pig
Tanimoto, T., OHTSUKI, Y., Sonobe, H., Takahashi, R., & Nomura, Y. (1988) · Veterinary Pathology · doi:10.1177/030098588802500418 · Cited by 20
Genome Editing with CompoZr Custom Zinc Finger Nucleases (ZFNs)
Hansen, K., Coussens, M. J., Sago, J., Subramanian, S., Gjoka, M., & Briner, D. (2012) · Journal of Visualized Experiments · doi:10.3791/3304-v · Cited by 12
Description of an intraperitoneal tumour xenograft survival model in the pig
Reymond, M. A., Tannapfel, A., Schneider, C. G., Scheidbach, H., Köver, S., Jung, A., Reck, T., KÖckerling, F., & Lippert, H. (2000) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0905 · Cited by 11
Mandibular osteosarcoma in a pig
WILLIAMSON, M., & BYRNE, A. (2006) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.2006.tb12799.x · Cited by 4
Cited by
The promise and challenge of therapeutic genome editing
Doudna, J. A. (2020) · Nature · doi:10.1038/s41586-020-1978-5 · Cited by 1,126
CRISPR in livestock: From editing to printing
Menchaca, A., dos Santos-Neto, P. C., Mulet, A. P., & Crispo, M. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.063 · Cited by 104
Gene transfer to plants by electroporation: methods and applications
Özyiğit, İ. İ. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05343-4 · Cited by 95
Improvements in Gene Editing Technology Boost Its Applications in Livestock
Périssé, I. V., Fan, Z., Singina, G. N., White, K. L., & Polejaeva, I. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.614688 · Cited by 96
Genome editing approaches to augment livestock breeding programs
Bishop, T., & Eenennaam, A. L. V. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.207159 · Cited by 85
Metadata
- Authors
- Tanihara, F., Hirata, M., Nguyen, N. T., Le, Q. A., Hirano, T., Takemoto, T., Nakai, M., Fuchimoto, D.-I., & Otoi, T.
- Affiliations
- Tokushima University (JP)
- Institute of Advanced Medical Sciences, Tokushima University (JP)
- National Agriculture and Food Research Organization (JP)
- Corresponding author
- Tanihara, Fuminori
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-10-23
- Volume
- 13
- Issue
- 10
- Pages
- e0206360
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6198999
- OpenAlex
- W2896848238
- Cited by
- 63
- References
- 39
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 15 · 2020: 12 · 2019: 6
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (publishedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Agriculture (2015-33522-24106, 2017-38420-26790)
- Nihon University
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health
- Division of Agriculture and Natural Resources, University of California
- University of California, Davis
- Japan Society for the Promotion of Science (17H03607, 18KT0024, 17H03938, 17K19325)
- Genome Center, University of California, Davis (1S10OD010786-01)
- Science and Technology Research Partnership for Sustainable Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Keywords
- TP53 mutation, p53, CRISPR/Cas9 genome editing, somatic mosaicism, osteosarcoma, Wilms tumor, malignant fibrous histiocytoma, tumor phenotype, single guide RNA
- MeSH terms
- Gene Editing, Animals, Disease Models, Animal, Genotype, Neoplasms, Phenotype, Swine, Zygote, Tumor Suppressor Protein p53, Gene Deletion, Histiocytoma, Benign Fibrous, Electroporation, Animals, Genetically Modified, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.